Malignant adnexal neoplasms

Modern Pathology

Volumn 19, Issue , 2006, Pages 93-126

  Neil Crowson, A ^a   Magro, Cynthia M ^b   Mihm, Martin C ^c  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Eccrine carcinoma; Sebaceous neoplasia

Indexed keywords

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADNEXA DISEASE; CANCER GRADING; CARCINOSARCOMA; CLINICAL FEATURE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; EPITHELIUM TUMOR; HAMARTOMA; HIDRADENOMA; HISTOLOGY; HISTOPATHOLOGY; HUMAN; NEOPLASM; PAGET SKIN DISEASE; PILOMATRIXOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEBACEOUS CARCINOMA; SEBACEOUS GLAND; SEBACEOUS GLAND TUMOR; SEBACEOUS NEVUS; SWEAT GLAND; SWEAT GLAND CARCINOMA; SWEAT GLAND TUMOR; TRICHILEMMOMA; TUBEROUS SCLEROSIS;

CA-15-3 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; SEBACEOUS GLANDS; SKIN NEOPLASMS;

EID: 31644440055     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800511     Document Type: Article

References (337)

1. Lever WF. Sebaceous adenoma. Review of the literature and report of a case. Arch Dermatol 1948;57:102-111.
2. Warren S, Warvi WN. Tumors of sebaceous glands. Am J Pathol 1943;19:441-460.
3. Prioleau PG, Santa Cruz DJ. Sebaceous gland neoplasia. J Cutan Pathol 1984;11:396-414.
4. Rulon DB, Helwig EB. Cutaneous sebaceous neoplasms. Cancer 1974;33:82-102.
5. Brownstein MH, Shapiro L. The pilosebaceous tumors. Int J Dermatol 1977;16:340-352.
6. Mehregan AH, Rahbari H. Benign epithelial tumors of the skin. II. Benign sebaceous tumors. Cutis 1977;19:317-320.
7. Reiffers J, Laugier P, Hunziker N. Sebaceous hyperplasias, keratoacanthomas, epitheliomas of the face, and cancer of the colon: A new entity? Dermatologica 1976;153:23-33.
8. Rulon DB, Helwig EB. Multiple sebaceous neoplasms of the skin: An association wtih multiple visceral carcinomas, especially of the colon. Am J Clin Pathol 1973;60:745-753.
9. Sciallis GF, Winkelmann RK. Multiple sebaceous adenomas and gastrointestinal carcinoma. Arch Dermatol 1974;110:913-916.
10. Housholder MS, Zeligman I. Sebaceous neoplasms associated with visceral carcinomas. Arch Dermatol 1980;116:61-64.
11. Tschang TP, Poulos E, Ho CK. Multiple sebaceous adenomas and internal malignant disease: A case report with chromosomal analysis. Hum Pathol 1976; 7:589-594.
12. Fahmy A, Burgdorf WHC, Schosser RH, et al. Muir-Torre syndrome. Reevaluation of the dermatological features and consideration of its relationship to the family cancer syndrome. Cancer 1973;49: 1898-1903.
13. Burgdorf WHC, Pitha J, Fahmy A. Muir-Torre syndrome. Histologic spectrum of sebaceous proliferations. Am J Dermatopathol 1986;8:202-208.
14. Davis DA, Cohen PR. Genitourinary tumors in men with the Muir-Torre syndrome. J Am Acad Dermatol 1995;33:909-912.
15. Lasser A, Carter DM. Multiple basal cell epitheliomas with sebaceous differentiation. Arch Dermatol 1973;107: 91-93.
16. McMullan FH. Sebaceous epithelioma. Arch Dermatol 1955;71:725-727.
17. Zackheim HS. The sebaceous epithelioma. Arch Dermatol 1964;89:711-724.
18. Okuda C, Ito M, Fujiwara H, et al. Sebaceous epithelioma with sweat gland differentiation. Am J Dermatopathol 1995;17:523-528.
19. Rothko F, Farmer ER, Zeligman I. Superficial epithelioma with sebaceous differentiation. Arch Dermatol 1980;116:329-331.
20. Friedman KJ, Boudreau S, Farmer ER. Superficial epithelioma with sebaceous differentiation. J Cutan Pathol 1987;14:193-197.
21. Lee MJ, Kim YC, Lew W. A case of superficial epithelioma with sebaceous differentiation. Yonsei Med J 2003;30:347-350.
22. Mahalingam M, Bhawan J, Finn R, et al. Tumor of the follicular infundibulum with sebaceous differentiation. J Cutan Pathol 2001;28:314-317.
23. Troy JL, Ackerman AB. Sebaceoma: A distinctive benign neoplasm of adnexal epithelium differentiating toward sebaceous cells. Am J Dermatopathol 1984;6:7-13.
24. Misago N, Mihara I, Ansai S-I, et al. Sebaceoma and related neoplasms with sebaceous differentiation. Am J Dermatopathol 2002;24:294-304.
25. Zaim MT. Sebocrine adenoma: An adnexal adenoma with sebaceous and apocrine poroma-like differentiation. Am J Dermatopathol 1988;10:311-318.
26. Grosshans E, Hanau D. L’adenome infundibulaire: Un porome folliculaire a’ differenciation sebacee et apocrine. Ann Dermatol Venereol 1981;108:59-66.
27. Misago N, Suse T, Uemura T, et al. Basal cell carcinoma with sebaceous differentiation. Am J Dermatopathol 2004;26:298-303.
28. Wick MR, Goellner JR, Wolfe III JT, et al. Adnexal carcinomas of the skin. II. Extraocular sebaceous carcinomas. Cancer 1985;56:1163-1172.
29. Wolfe JT, Wick MR, Campbell RJ. Sebaceous carcinomas of the oculocutaneous adnexa and extraocular skin. In: Wick MR (ed). Pathology of Unusual Malignant Cutaneous Tumors. Marcel-Dekker: New York, 1985, pp 77-106.
30. Wolfe III JT, Campbell RJ, Yeatts RP, et al. Sebaceous carcinoma of the eyelid: Errors in clinical and pathologic diagnosis. Am J Surg Pathol 1984;8: 597-606.
31. Rao NA, Hidayat AA, McLean IW, et al. Sebaceous carcinoma of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year followup data. Hum Pathol 1982;13:113-122.
32. Ni C, Kuo PK. Meibomian gland carcinoma: A clinicopathological study of 156 cases with longperiod followup of 100 cases. Jpn J Ophthalmol 1979;23:388-401.
33. Graham RM, McKee PH, McGibbon D. Sebaceous carcinoma. Clin Exp Dermatol 1984;9:466-471.
34. Doxanas MT, Green WR. Sebaceous gland carcinoma: Review of 40 cases. Arch Ophthalmol 1984;102: 245-249.
35. Ausidio RA, Lodeville O, Quaglivolo V, et al. Sebaceous carcinoma arising from the eyelid and from extraocular sites. Tumori 1987;73:531-535.
36. Nguyen GK, Mielke BW. Extraocular sebaceous carcinoma with intraepidermal (pagetoid) spread. Am J Dermatopathol 1987;9:304-305.
37. Nelson BR, Hamlet KR, Gillard M, et al. Sebaceous carcinoma. J Am Acad Dermatol 1995;33:1-15.
38. Harvey PA, Parsons MA, Rennie IG. Primary sebaceous carcinoma of lacrimal gland: A previously unreported primary neoplasm. Eye 1994;8: 592-595.
39. Ansai S, Hashimoto H, Aoki T, et al. A histochemical and immunohistochemical study of extraocular sebaceous carcinoma. Histopathology 1993;22:127-133.
40. Shields JA, Demirci H, Marr BP, et al. Sebaceous carcinoma of the eyelids: Personal experience with 60 cases. Ophthalmology 2004;111:2151-2157.
41. Oppenheim AR. Sebaceous carcinoma of the penis. Arch Dermatol 1981;117:306-307.
42. Bassetto F, Baraziol R, Sottosanti MV, et al. Biological behaviour of the sebaceous carcinoma of the head. Dermatol Surg 2004;30:472-476.
43. Cohen PR, Kohn SR. Association of sebaceous gland tumors and internal malignancy: The Muir-Torre syndrome. Am J Med 1991;90:606-613.
44. Moreno C, Jacyk WK, Judd MJ, et al. Highly aggressive extraocular sebaceous carcinoma. Am J Dermatopathol 2001;23:450-455.
45. Ohara M, Sotozono C, Tsuchihashi Y, et al. Ki-67 labeling index as a marker of malignancy in ocular surface neoplasms. Jpn J Ophthalmol 2004;48:524-529.
46. Luderschmidt C, Plewig G. Circumscribed sebaceous gland hyperplasia: Autoradiographic and histoplanometric studies. J Invest Dermatol 1978;70:207-209.
47. Kudoh K, Hosokawa M, Miyazawa T, et al. Giant solitary sebaceous gland hyperplasia clinically simulating epidermoid cyst. J Cutan Pathol 1988;15: 396-398.
48. Nakamura SI, Nakayama K, Nishihara K, et al. Sebaceous carcinoma, with special reference to the histopathologic differential diagnosis. J Dermatol 1988;15:55-59.
49. Misago N, Narisawa Y. Sebaceous carcinoma with apocrine differentiation. Am J Dermatopathol 2001; 23:50-57.
50. Kazakov DV, Kutzner H, Rutten A, et al. Carcinoidlike pattern in sebaceous neoplasms: Another distinctive, previously unrecognized pattern in extra-ocular sebaceous carcinoma and sebaceoma. Am J Dermatopathol 2005;27:195-203.
51. Abbott JJ, Hernandez-Rios P, Amirkhan RH, et al. Cystic sebaceous neoplasms in Muir-Torre syndrome. Arch Pathol Lab Med 2003;127:614-617.
52. Sinard JH. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous carcinoma. Arch Ophthalmol 1999;117: 776-783.
53. Ansai S, Mitsuhashi Y, Kondo S, et al. Immunohistochemical differentiation of extra-ocular sebaceous carcinoma from other skin cancers. J Dermatol 2004;31:998-1008.
54. Hassanein AM. Sebaceous carcinoma and the Tantigen. Semin Cutan Med Surg 2004;23:62-72.
55. Rishi K, Font RL. Sebaceous gland tumors of the eyelids and the conjunctiva in the Muir-Torres syndrome: A clinicopathological study of five cases and literature review. Ophthal Plast Reconstr Surg 2004;20:31-36.
56. Swanson PE, Wick MR. Immunohistochemistry of cutaneous tumors. In: Leong ASY (ed). Applied Immunohistochemistry for the Surgical Pathologist. Edward Arnold: London, 1993, pp 269-308.
57. Crowson AN, MacInnes C, Carlson-Sweet K, et al. Clear cell atypical fibroxanthoma: A clinicopathological study. J Cutan Pathol 2002;29:374-381.
58. Crowson AN, Taylor JR, Magro CM. Clear cell vs ‘conventional’ atypical fibroxanthoma: A clinicopathologic study of 10 cases. Lab Invest 2003;90A.
59. Jensen K, Wilkinson B, Wines N, et al. Procollagen 1 expression in atypical fibroxanthoma and other tumors. J Cutan Pathol 2004;31:57-61.
60. McBride SR, Leonard N, Reynolds NJ. Loss of p21 (WAF1) compartmentalisation in sebaceous carcinoma compared with sebaceous hyerplasia and sebaceous adenoma. J Cutan Pathol 2002;55: 763-766.
61. Jimenez FJ, Burchette Jr JL, Grichnik JM, et al. BER-EP4 immunoreactivity in normal skin and cutaneous neoplasms. Mod Pathol 1995;8:854-858.
62. Mehregan AH, Pinkus H. Life history of organoid nevi: Special reference to nevus sebaceus of Jadassohn. Arch Dermatol 1965;91:574-587.
63. Morioka S. The natural history of nevus sebaceus. J Cutan Pathol 1985;12:200-213.
64. Lentz CL, Altman J, Mopper C. Nevus sebaceus of Jadassohn. Arch Dermatol 1968;97:294-296.
65. Wilson-Jones E, Heyl T. Nevus sebaceus: A report of 140 cases with special regard to the development of secondary malignant tumors. Br J Dermatol 1970;82: 99-105.
66. Clancy RR, Kurtz MB, Baker D, et al. Neurologic manifestations of the organoid nevus syndrome. Arch Neurol 1985;42:236-240.
67. Zaremba J. Jadassohn’s nevus phakomatosis: A study based on a review of 37 cases. J Ment Defic Res 1977;22:103-122.
68. Alessi E, Wong SN, Advani HH, et al. Nevus sebaceus is associated with unusual neoplasms: An atlas. Am J Dermatopathol 1988;10:116-127.
69. Crowson AN, Magro CM. Desmoplastic trichilemmoma and its association with basal cell carcinoma. Am J Dermatopathol 1996;18:43-48.
70. Ng WK. Nevus sebaceus with apocrine and sebaceous differentiation. Am J Dermatopathol 1996;18: 420-423.
71. Crowson AN, Magro CM, Kadin M, et al. Differential expression of bcl-2 oncogene in human basal cell carcinoma. Hum Pathol 1996;27:355-359.
72. Domingo J, Helwig EB. Malignant neoplasms associated with nevus sebaceus of Jadassohn. J Am Acad Dermatol 1979;1:545-556.
73. Tarkhan H, Domingo J. Metastasizing eccrine porocarcinoma developing in a nevus sebaceus of Jadassohn: Report of a case. Arch Dermatol 1985; 121:413-415.
74. Headington JT. Tumors of the hair follicle: A review. Am J Pathol 1976;85:480-505.
75. Ten Seldam REJ. Tricholemmocarcinoma. Australas J Dermatol 1977;18:62-72.
76. Krumrey KW. The tricholemmal carcinoma: Report of a case with review of the literature. Aktuel Dermatol 1984;10:70-72.
77. Schell H, Haneke E. Tricholemmal carcinoma: Report of 11 cases. Hautarzt 1986;37:384-387.
78. Grouls V. Tricholemmale Keratose und tricholemmales Karzinom. Hautarzt 1987;38:335-341.
79. Boscaino A, Terracciano LM, Donofrio V, et al. Trichilemmal carcinoma: A study of seven cases. J Cutan Pathol 1992;19:94-99.
80. Swanson PE, Marrogi AJ, Williams DJ, et al. Trichilemmal carcinoma. J Cutan Pathol 1992;19:100-109.
81. Reis JP, Tellechea O, Cunha MF, et al. Trichilemmal carcinoma: Review of eight cases. J Cutan Pathol 1993;20:44-49.
82. Wong TY, Suster S. Trichilemmal carcinoma: A clinicopathologic study of 13 cases. Am J Dermatopathol 1994;16:463-473.
83. Garrett AB, Azmi FH, Ogburia KS. Trichilemmal carcinoma: A rare cutaneous malignancy: A report of two cases. Dermatol Surg 2004;30:113-115.
84. Lai TF, Huilgol SC, James CL, et al. Trichilemmal carcinoma of the upper eyelid. Acta Ophthalmol Scand 2003;81:536-538.
85. Allee JE, Cotsarelis G, Solky B, et al. Multiple recurrent trichilemmal carcinoma with perineural invasion and cytokeratin 17 positivity. Dermatol Surg 2003;29:886-889.
86. Ohnishi T, Watanabe S. Immunohistochemical analysis of cytokeratin expression in various trichogenic tumors. Am J Dermatopathol 1999;21:337-343.
87. Haas N, Audring H, Sterry W. Carcinoma arising in a proliferating trichilemmal cyst expresses fetal and trichilemmal hair phenotype. Am J Dermatopathol 2002;24:340-344.
88. Mori O, Hachisuka H, Sasai Y. Proliferating trichilemmal cyst with spindle cell carcinoma. Am J Dermatopathol 1990;12:479-484.
89. Alvarez-Quinones M, Garijo MF, Fernandez F, et al. Malignant aneuploid spindle cell transformation in a proliferating trichilemmal tumor. Acta Dermatol Venereol 1993;73:444-446.
90. Marrogi AJ, Wick MR, Dehner LP. Pilomatrical neoplasms in children and young adults. Am J Dermatopathol 1992;14:87-94.
91. Kaddu S, Soyer HP, Hodl S, et al. Morphological stages of pilomatricoma. Am J Dermatopathol 1996;18:333-338.
92. Ter Poorten HJ, Sharbaugh AH. Extruding pilomatricoma: Report of a case. Cutis 1978;22:47-49.
93. Tsoitis G, Mandinaos C, Kanitakis JC. Perforating calcifying epithelioma of Malherbe with a rapid evolution. Dermatologica 1984;168:233-237.
94. Zulaica A, Peteiro C, Quintas C, et al. Perforating pilomatricoma. J Cutan Pathol 1988;15:409-411.
95. Alli N, Gungor E, Artuz F. Perforating pilomatricoma. J Am Acad Dermatol 1996;35:116-118.
96. Lee WS, Yoo MS, Ahn SK. Anetodermic cutaneous changes overlying pilomatricoma. Int J Dermatol 1995;34:144-145.
97. Shames BS, Nassif A, Bailey CS, et al. Secondary anetoderma involving a pilomatricoma. Am J Dermatopathol 1994;16:557-560.
98. Forbis R, Helwig EB. Pilomatrixoma (calcifying epithelioma). Arch Dermatol 1961;83:606-618.
99. Moehlenbeck FW. Pilomatrixoma (calcifying epithelioma). Arch Dermatol 1973;108:532-534.
100. Taaffe A, Wyatt EH, Bury HPR. Pilomatrixoma (Malherbe). A clinical and histological survey of 78 cases. Int J Dermatol 1988;27:477-480.
101. Kaddu S, Soyer HP, Cerroni L, et al. Clinical and histopathological spectrum of pilomatricoma in adults. Int J Dermatol 1994;33:705-708.
102. Bassarova A, Nesland JM, Sebloev T, et al. Pilomatrix carcinoma with lymph node metastases. J Cutan Pathol 2004;31:330-335.
103. Inglefield CJ, Muir IF, Gray ES. Aggressive pilomatricoma in childhood. Ann Plast Surg 1994;33: 656-658.
104. Lopansri S, Mihm MC. Pilomatrix carcinoma or calcifying epitheliocarcinoma of Malherbe: A case report and review of the literature. Cancer 1980;45: 2368-2373.
105. Gray M, Parhizgar B, Beerman H. Malignant pilomatrixoma. Arch Dermatol 1984;120:770-773.
106. Manivel JC, Wick MR, Mukai K. Pilomatrix carcinoma: An immunohistochemical comparison with benign pilomatrixoma and other benign lesions of pilar origin. J Cutan Pathol 1986;13:22-29.
107. Gould E, Kurzon R, Kowalczyk AP, et al. Pilomatrix carcinoma with pulmonary metastases: A report of a case. Cancer 1984;54:370-372.
108. Van der Walt JD, Rohlova B. Carcinomatous transformation in a pilomatrixoma. Am J Dermatopathol 1984;6:63-69.
109. Weedon D, Bell J, Maize J. Matrical carcinoma of the skin. J Cutan Pathol 1980;7:39-42.
110. Reed RJ, Lamar LM. Invasive hair matrix tumors of the scalp: Invasive pilomatrixoma. Arch Dermatol 1966;94:310-316.
111. Martelli G, Giardini R. Pilomatrix carcinoma: A case report and review of the literature. Eur J Surg Oncol 1994;20:703-704.
112. Panico L, Manivel JC, Pettinato G, et al. Pilomatrix carcinoma. Tumori 1994;80:309-314.
113. Sau P, Lupton GP, Graham JH. Pilomatrix carcinoma. Cancer 1993;71:2491-2498.
114. Zagarella SS, Kneale KL, Stern HS. Pilomatrix carcinoma of the scalp. Aust J Dermatol 1992;33: 39-42.
115. Niedermeyer HP, Peris K, Hofler H. Pilomatrix carcinoma with multiple visceral metastases: Report of a case. Cancer 1996;77:1311-1314.
116. Rahbari H, Mehregan AH. Pilary complex carcinoma: An adnexal carcinoma of the skin with differentiation towards the components of the pilary complex. J Dermatol 1993;20:630-637.
117. Sanchez-Yus E, Requena L, Simon P, et al. Complex adnexal tumor of the primary epithelial germ with distinct patterns of superficial epithelioma with sebaceous differentiation, immature trichoepithelioma, and apocrine adenocarcinoma. Am J Dermatopathol 1992;14:245-252.
118. Wick MR, Swanson PE, LeBoit PE, et al. Lymphoepithelioma-like carcinomas of the skin with adnexal differentiation. J Cutan Pathol 1991;18:93-102.
119. Requena L, Sanchez-Yus E, Jimenez E, et al. Lymphoepithelioma-like carcinoma of the skin: A light microscopic and immunohistochemical study. J Cutan Pathol 1994;21:541-548.
120. Barr RJ, Goodman MM. Neurofollicular hamartoma. A light microscopic and immunohistochemical study. J Cutan Pathol 1989;16:336-341.
121. Nova MP, Zung M, Halperin A. Neurofollicular hamartoma. A clinicopathological study. Am J Dermatopathol 1991;13:459-462.
122. Sangueza OP, Requena L. Neurofollicular hamartoma. A new histogenetic interpretation. Am J Dermatopathol 1994;16:150-154.
123. Tuthill RJ, Clark Jr WH, Levene A. Pilar neurocristic hamartoma: Its relationship to blue nevus and equine melanotic disease. Arch Dermatol 1982;118:592-596.
124. Crowson AN, Magro CM, Clark WHC. Pilar neurocristic hamartoma (letter). J Am Acad Dermatol 1996; 34:715.
125. Pathy AL, Helm TN, Elston D, et al. Malignant melanoma arising in a blue nevus with features of pilar neurocristic hamartoma. J Cutan Pathol 1993;20: 459-464.
126. Pearson JP, Weiss SW, Headington JT. Cutaneous malignant melanotic neurocristic tumors arising in neurocristic hamartomas: A melanocytic tumor morphologically and biologically distinct from common melanoma. Am J Surg Pathol 1996;20:665-677.
127. Page DL, Anderson TJ, Sakamoto G. Infiltrating carcinoma: Major histological types. In: Page DL, Anderson TJ (eds). Diagnostic Histopathology of the Breast. Churchill-Livingstone: New York, 1987, pp 193-295.
128. Busam KJ, Tan LK, Granter SR, et al. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Mod Pathol 1999;12:786-793.
129. Hiatt KM, Pilow JL, Smoller BR. Her-2 expression in cutaneous eccrine and apocrine neoplasms. Mod Pathol 2004;17:28-32.
130. Qureshi HS, Ormsby AH, Lee MW, et al. The diagnostic utility of p63, CK5/6, CK 7, and Ck 20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. Cutan Pathol 2004;31: 145-152.
131. Plumb SJ, Argenyi ZB, Stone MS, et al. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma. Am J Dermatopathol 2004;26:447-451.
132. Ivan D, Hafeez Diwan A, Prieto VG. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. Mod Pathol 2005;18:137-142.
133. Goedde TA, Bumpers H, Fiscella J, et al. Eccrine porocarcinoma. J Surg Oncol 1994;55:261-264.
134. Poiares-Baptista A, Tellechea O, Reis JP, et al. Eccrine porocarcinoma: A review of 24 cases. Ann Dermatol Venereol 1993;120:107-115.
135. Snow SN, Reizner GT. Eccrine porocarcinoma of the face. J Am Acad Dermatol 1992;27:306-311.
136. Yamamoto O, Haratake J, Yokoyama S, et al. A histopathological and ultrastructural study of eccrine porocarcinoma with special reference to its subtypes. Virchows Arch A Pathol Anat Histopathol 1992; 420:395-401.
137. Turner JJ, Maxwell L, Bursle CA. Eccrine porocarcinoma. Pathology 1982;14:469-475.
138. Shaw M, McKee PH, Lowe D, et al. Malignant eccrine poroma: A study of twenty seven cases. Br J Dermatol 1982;107:675-680.
139. Bottles K, Sagebiel RW, McNutt NS, et al. Malignant eccrine poroma. Cancer 1984;53:1579-1585.
140. Ryan JF, Darley CR, Pollock DJ. Malignant eccrine poroma: Report of three cases. J Clin Pathol 1986; 39:1099-1104.
141. Mehregan AH, Hashimoto K, Rahbari H. Eccrine adenocarcinoma: A clinicopathologic study of 35 cases. Arch Dermatol 1983;119:104-114.
142. Akalin T, Sen S, Yuceturk A, et al. p53 protein expression in eccrine poroma and porocarcinoma. Am J Dermatopathol 2001;23:402-406.
143. Wick MR, Swanson PE, Barnhill RL. Sweat gland tumors. In: Barnhill RL, Crowson AN (eds). Textbook of Dermatopathology, 2nd edn. McGraw-Hill Co.: New York, 2004, pp 745-784.
144. Miyashita M, Suzuki H. In situ porocarcinoma: A case with malignant expression in clear tumor cells. Int J Dermatol 1993;32:749-750.
145. Bardach H. Hidroacanthoma simplex with in situ porocarcinoma. J Cutan Pathol 1978;5:236-248.
146. Isikawa K. Malignant hidroacanthoma simplex. Arch Dermatol 1972;104:529-532.
147. Moreno R, Salvatella N, Guix M, et al. Malignant hidroacanthoma simplex. Dermatologica 1984;169: 318-322.
148. Manteaux A, Cohen PR, Rapini RP. Zosteriform and epidermotropic metastasis: Report of two cases. J Dermatol Surg Oncol 1992;18:97-100.
149. Hara K, Kamiya S. Pigmented eccrine porocarcinoma: A mimic of malignant melanoma. Histopathology 1995;27:86-88.
150. Wick MR, Swanson PE. Cutaneous Adnexal Tumors: A Guide to Pathologic Diagnosis. ASCP Press: Chicago, 1991.
151. Hashimoto K, Mehregen AH, Kumakiri M. Tumors of Skin Appendages. Butterworths: Boston, 1987, pp 48-51.
152. Van der Putte SC. The pathogenesis of familial multiple cylindromas, trichoepitheliomas, milia, and spiradenomas. Am J Dermatopathol 1995;17: 271-280.
153. Cooper PH. Carcinomas of sweat glands. Pathol Annu 1987;22(Part 1):83-124.
154. Ohta M, Hiramoto M, Fujii M, et al. Nodular hidradenocarcinoma on the scalp of a young woman: Case report and review of literature. Dermatol Surg 2004;30:1265-1268.
155. Fukamizu H, Tomita K, Inoue K, et al. Primary mucinous carcinoma of the skin. J Dermatol Surg Oncol 1993;19:625-628.
156. Ghamande SA, Kasznick J, Griffiths CT, et al. Mucinous adenocarcinomas of the vulva. Gynecol Oncol 1995;57:117-120.
157. Katoh N, Hirano S, Hosokawa Y, et al. Mucinous carcinoma of the skin: Report of a case with DNA cytofluorometric study. J Dermatol 1994;21: 117-121.
158. Mendoza S, Helwig EB. Mucinous (adenocystic) carcinoma of the skin. Arch Dermatol 1971;103: 68-78.
159. Rodriguez MM, Lubowitz RM, Shannon GM. Mucinous (adenocystic) carcinoma of the eyelid. Arch Ophthalmol 1973;89:493-494.
160. Grossman JR, Izuno GT. Primary mucinous (adenocystic) carcinoma of the skin. Arch Dermatol 1974;110:274-276.
161. Santa Cruz DJ, Meyers JH, Gnepp DR, et al. Primary mucinous carcinoma of the skin. Br J Dermatol 1978;68:645-653.
162. Yeung KY, Stinson JC. Mucinous (adenocystic) carcinoma of sweat glands with widespread metastasis. Cancer 1977;39:2556-2562.
163. Pilgram JP, Kloss SG, Wolfish PS, et al. Primary mucinous carcinoma of the skin with metastases to the lymph nodes. Am J Dermatopathol 1985;7: 461-469.
164. Rahilly MA, Beattie GJ, Lessells AM. Mucinous eccrine carcinoma of the vulva with neuroendocrine differentiation. Histopathology 1995;27:82-86.
165. Minami Y, Uede K, Sagawa K, et al. Immunohistochemical staining of cutaneous tumours with G-81, a monoclonal antibody to dermcidin. Br J Dermatol 2004;141:165-169.
166. Rosen T. Cutaneous metastases. Med Clin North Am 1980;64:885-900.
167. Koh BK, Choi JM, Yi JY, et al. Recurrent primary cutaneous adenoid cystic carcinoma of the scrotum. Int J Dermatol 2001;40:724-725.
168. Chu SS, Chang YL, Lou PJ. Primary cutaneous adenoid cystic carcinoma with regional lymph node metastasis. J Laryngol Otol 2001;115:673-675.
169. Urso C, Bondi R, Paglierani M, et al. Carcinomas of sweat glands: Report of 60 cases. Arch Pathol Lab Med 2001;125:498-505.
170. Chang SE, Ahn SJ, Choi JH, et al. Primary adenoid cystic carcinoma of skin with lung metastasis. J Am Acad Dermatol 1999;40:640-642.
171. DeLucia A, Gambardella T, Carra P, et al. A case of highly aggressive adenoid cystic carcinoma of the external auditory canal. Acta Otorhinolaryngol Ital 2004;24:354-356.
172. Wassef M, Thomas V, Deffrennes D, et al. Primary adenoid cystic carcinoma of the skin: Histologic and ultrastructural study of two cases localized in the external auditory canal. Ann Pathol 1995;15:150-155.
173. Eckert F, Pfau A, Landthaler M. Adenoid cystic sweat gland carcinoma: A clinicopathologic and immunohistochemical study. Hautarzt 1994;45:318-323.
174. Matsumura T, Kumakiri M, Ohkaware A, et al. Adenoid cystic carcinoma of the skin: An immunohistochemical and ultrastructural study. J Dermatol 1993;20:164-170.
175. Cooper PH, Adelson GL, Holthaus WH. Primary cutaneous adenoid cystic carcinoma. Arch Dermatol 1984;120:774-777.
176. Wick MR, Swanson PE. Primary adenoid cystic carcinoma of the skin. Am J Dermatopathol 1986; 8:2-13.
177. Seab JA, Graham JH. Primary cutaneous adenoid cystic carcinoma. J Am Acad Dermatol 1987;17: 113-118.
178. Van der Kwast TH, Vuzevski VD, Ramaekers F. Primary cutaneous adenoid cystic carcinoma. Br J Dermatol 1988;118:567-576.
179. Dardick I, van Nostrand AW, Phillips MJ. Histogenesis of salivary gland pleomorphic adenoma (mixed tumor) with evaluation of the role of myoepithelial cells. Hum Pathol 1982;13:62-75.
180. Inaloz HS, Patel GK, Knight AG. An aggressive treatment for aggressive digital papillary adenocarcinoma. Cutis 2002;69:179-182; quiz 210.
181. Smith KJ, Skelton HG, Holland TT. Recent advances and controversies concerning adnexal neoplasms. Dermatol Clin 1992;10:117-160.
182. Goldstein DJ, Barr RJ, Santa Cruz DJ. Microcystic adnexal carcinoma: A distinct clinicopathologic entity. Cancer 1982;50:566-572.
183. Kao GF, Graham JH, Helwig EB. Aggressive digital papillary adenoma and adenocarcinoma (abstract). Arch Dermatol 1984;120:1612.
184. Rulon DB, Helwig EB. Papillary eccrine adenoma. Arch Dermatol 1977;113:596-598.
185. Elpern DJ, Farmer ER. Papillary eccrine adenoma. Arch Dermatol 1978;114:1241.
186. Cooper PH, Frierson HF. Papillary eccrine adenoma. Arch Pathol Lab Med 1984;108:55-57.
187. Urmacher C, Lieberman PH. Papillary eccrine adenoma: A light microscopic and immunohistochemical study. Am J Dermatopathol 1987;9:243-249.
188. Falck VG, Jordaan HF. Papillary eccrine adenoma. A tubulopapillary hidradenoma with eccrine differentiation. Am J Dermatopathol 1986;8:64-72.
189. Swanson PE, Cherwitz DL, Neumann MP, et al. Eccrine sweat gland carcinoma: An histologic and immunohistochemical study of 32 cases. J Cutan Pathol 1987;14:65-86.
190. Sexton M, Maize JC. Papillary eccrine adenoma: A light microscopic and immunohistochemical study. J Am Acad Dermatol 1988;18:1114-1120.
191. Kanitakis J, Hermier C, Thivolet J. Papillary eccrine adenoma. Am J Dermatopathol 1988;10: 180-182.
192. Jerasutus S, Suvanprakorn P, Wongchinchai M. Papillary eccrine adenoma: An electron microscopic study. J Am Acad Dermatol 1989;20:1111-1114.
193. Hashimoto K, Kato I, Taniguchi Y, et al. Papillary eccrine adenoma. Immunohistochemical and ultrastructural analyses. J Dermatol Sci 1990;1:65-71.
194. Requena L, Pena M, Sanchez M, et al. Papillary eccrine adenoma—a light-microscopic and immunohistochemical study. Clin Exp Dermatol 1990;15: 425-428.
195. Aloi F, Pich A. Papillary eccrine adenoma: A histopathological and immunohistochemical study. Dermatologica 1991;182:47-51.
196. Fox SB, Cotton DW. Tubular apocrine adenoma and papillary eccrine adenoma. Entities or unity? Am J Dermatopathol 1992;14:149-154.
197. Lever WF. Schaumberg-Lever. Histopathology of the Skin, 7th edn. JB Lippincott & Co.: Philadelphia, 1989, pp 638-639.
198. Galadari E, Mehregan AH, Lee KC. Malignant transformation of eccrine tumors. J Cutan Pathol 1987; 14:15-22.
199. Duke WH, Sherrod TT, Lupton GP. Aggressive digital papillary adenocarcinoma (aggressive digital papillary adenoma and adenocarcinoma revisited). Am J Surg Pathol 2000;24:775-784.
200. Kao GF, Helwig EG, Graham JH. Aggressive digital papillary adenoma and adenocarcinoma. A clinicopathological study of 57 patients, with histochemical, immunopathological, and ultrastructural observations. J Cutan Pathol 1987;14:129-146.
201. Guccion JG, Patterson RH, Nayar R, et al. Papillary eccrine adenoma: An ultrastructural and immunohistochemical study. Ultrastruct Pathol 1998;22:263-269.
202. Ichikawa E, Okabe S, Umebayashi Y, et al. Papillary eccrine adenoma: Immunohistochemical studies of keratin expression. J Cutan Pathol 1997;24:564-570.
203. Elder DE, Elenitsas R, Ragsdale B. Tumors of the epidermal appendages. In: Elder DE, Johnson BE, Jaworsky C, Elenitsas R (eds). Lever’s Histopathology of the Skin, 8th edn. JB Lippincott Co.: Philadelphia, 1997, pp 747-803.
204. Malafa MP, McKesey P, Stone S, et al. Sentinel node biopsy for aggressive digital papillary adenocarcinoma. Dermatol Surg 2000;26:580-583.
205. Daigeler A, Fansa H, Tammer M, et al. Aggressive digital papillary adenocarcinoma—a case report. Handchir Mikrochir Plast Chir 2002;34:137-139.
206. Wick MR, Cooper PH, Swanson PE, et al. Microcystic adnexal carcinoma: An immunohistochemical comparison with other cutaneous appendage tumors. Arch Dermatol 1990;126:189-194.
207. Nickoloff BJ, Fleischmann HE, Carmel J. Microcystic adnexal carcinoma: Immunohistologic observations suggesting dual (pilar and eccrine) differentiation. Arch Dermatol 1986;122:290-294.
208. Callahan EF, Vidimos AT, Bergfeld WF. Microcystic adnexal carcinoma (MAC) of the scalp with extensive pilar differentiation. Dermatol Surg 2002;28:536-539.
209. Ongenae KC, Verhaegh ME, Vermeulen AH, et al. Microcystic adnexal carcinoma: An uncommon tumor with debatable origin. Dermatol Surg 2001;27: 979-984.
210. Ohtsuka H, Nagamatsu S. Microcystic adnexal carcinoma: Review of 51 Japanese patients. Dermatology 2002;204:190-193.
211. Snow S, Madjar DD, Hardy S, et al. Microcystic adnexal carcinoma: Report of 13 cases and review of the literature. Dermatol Surg 2001;27:401-408.
212. Chiller K, Passaro D, Scheuller M, et al. Microcystic adnexal carcinoma: Forty-eight cases, their treatment, and their outcome. Arch Dermatol 2000;136:1355-1359.
213. Carroll P, Goldstein GD, Brown Jr CW. Metastatic microcystic adnexal carcinoma in an immunocompromised patient. Dermatol Surg 2000;26:531-534.
214. Friedman PM, Friedman RH, Jiang SB, et al. Microcystic adnexal carcinoma: Collaborative series review and update. J Am Acad Dermatol 1999;41:225-231.
215. Beer KT, Buhler SS, Mullis P, et al. A microcystic adnexal carcinoma in the auditory canal 15 years after radiotherapy of a 12-year-old boy with nasopharynx carcinoma. Strahlender Onkol 2005;181: 405-410.
216. Ohtsuka H, Nozawa R, Kushida Y. Synchronous microcystic adnexal carcinoma and gastric cancer with review of the literature. J Dermatol 2005;32: 43-47.
217. Kachemoune A, Olbricht SM, Johnson DS. Microcytstic adnexal carcinoma: Report of four cases treated with Mohs’ micrographic surgical technique. Int J Dermatol 2005;44:507-512.
218. Cooper PH, Mills SE, Leonard DD, et al. Sclerosing sweat duct (syringomatous) carcinoma. Am J Surg Pathol 1985;9:422-433.
219. Cooper PH. Sclerosing carcinomas of sweat ducts (microcystic adnexal carcinoma). Arch Dermatol 1986;122:261-264.
220. Berg JW, McDivitt RW. Pathology of sweat gland carcinomas. Pathol Annu 1968;3:123-144.
221. Lipper S, Peiper SC. Sweat gland carcinoma with syringomatous features. Cancer 1979;44:157-163.
222. Cooper PH, Mills SE. Microcystic adnexal carcinoma. J Am Acad Dermatol 1984;10:908-914.
223. McAlvany JP, Stonecipher MR, Leshin B, et al. Sclerosing sweat duct carcinoma in an 11 year old boy. J Dermatol Surg Oncol 1994;20:767-768.
224. Batsakis JG, El-Naggar AK, Weber RS. Two perplexing skin tumors: Microcystic adnexal carcinoma and keratoacanthoma. Ann Otol Rhinol Laryngol 1994; 103:829-832.
225. LeBoit PE, Sexton M. Microcystic adnexal carcinoma of the skin. A reappraisal of the differentiation and differential diagnosis of an underrecognized neoplasm. J Am Acad Dermatol 1993;29:609-618.
226. Hesse RJ, Scharfenberg JC, Ratz JL, et al. Eyelid microcystic adnexal carcinoma. Arch Ophthalmol 1995;113:494-496.
227. Verdier-Sevrain S, Thomine E, Lauret P, et al. Syringomatous carcinoma: Apropos of three cases with a review of the literature. Ann Pathol 1995;15: 280-284.
228. Schlipper JH, Holecek BU, Sievers KW. A tumor derived from Ebner’s glands: Microcystic adnexal carcinoma of the tongue. J Laryngol Otol 1995;109: 1211-1214.
229. Yus ES, Caballero LR, Salazar IG, et al. Clear cell syringoid eccrine carcinoma. Am J Dermatopathol 1987;9:225-231.
230. Smith KJ, Williams J, Corbett D, et al. Microcystic adnexal carcinoma: An immunohistochemical study including markers of proliferation and apoptosis. Am J Surg Pathol 2001;25:464-471.
231. Pruzam DL, Esterly NB, Prose NS. Eruptive syringoma. Arch Dermatol 1989;125:1119-1120.
232. Brownstein MH, Shapiro L. Desmoplastic trichoepithelioma. Cancer 1977;40:2979-2986.
233. Salasche SJ, Amonette RA. Morpheaform basal cell epitheliomas. J Dermatol Surg Oncol 1981;7: 387-394.
234. Smith KJ, Skelton HG. Familial syringomas: An example of gonadal mosaicism. Cutis 2001;68: 293-295.
235. Draznin M. Hereditary syringomas: A case report. Dermatol Online J 2004;115:19.
236. Biernat W, Jablkowski W. Syringomatous adenoma of the nipple. Pol J Pathol 2000;51:201-202.
237. Banks ER, Cooper PH. Adenosquamous carcinoma of the skin: A report of 10 cases. J Cutan Pathol 1991;18:227-234.
238. Weidner N, Foucar E. Adenosquamous carcinoma of the skin: An aggressive mucin-and gland-forming squamous carcinoma. Arch Dermatol 1985;121: 775-779.
239. Sakamoto F, Ito M, Oguro K, et al. Adenosquamous carcinoma of the skin: Ultrastructural and immunohistochemical studies. Jpn J Dermatol 1990;100: 1183-1190.
240. Azorin D, Lopez-Rios F, Ballestin C, et al. Primary cutaneous adenosquamous carcinoma: A case report and review of the literature. J Cutan Pathol 2001;28:542-545.
241. Landman G, Farmer ER. Primary cutaneous mucoepidermoid carcinoma: Report of a case. J Cutan Pathol 1991;18:56-59.
242. Wenig BL, Sciubba JJ, Goodman RS, et al. Primary cutaneous mucoepidermoid carcinoma of the anterior neck. Laryngoscope 1983;93:464-467.
243. Friedman KJ. Low-grade primary cutaneous adenosquamous (mucoepidermoid) carcinoma. Am J Dermatopathol 1989;11:43-50.
244. Smoller BR, Narurkar V. Mucoepidermoid carcinoma metastatic to the skin: An histologic mimic of a primary sweat gland carcinoma. J Dermatol Surg Oncol 1992;18:365-368.
245. Metcalf JS, Maize JC, Shaw EB. Bronchial mucoepidermoid carcinoma metastatic to skin: Report of a case and review of the literature. Cancer 1986;58:2556-2559.
246. Barsky SH, Martin SE, Matthews M, et al. ‘Low grade’ mucoepidermoid carcinoma of the bronchus with ‘high grade’ biological behavior. Cancer 1983;51: 1505-1509.
247. Revercomb CH, Reitmeyer WJ, Pulitzer DR. Clear cell variant of mucoepidermoid carcinoma of the skin. J Am Acad Dermatol 1993;29:642-644.
248. Diwan AH, Smith KJ, Brown R, et al. Mucoepidermoid carcinoma arising within nevus sebaceus of Jadassohn. J Cutan Pathol 2003;30:652-655.
249. Wildemore JK, Lee JB, Humphreys TR. Mohs surgery for malignant eccrine neoplasms. Dermatol Surg 2004;30:1574-1579.
250. Fernandez-Figueras MT, Fuente MJ, Bielsa I, et al. Low-grade mucoepidermoid carcinoma on the vermilion border of the lip. Am J Dermatopathol 1997; 19:197-201.
251. Harris TJ, Jine JD, Berman RS, et al. Neutrophilic eccrine hidradenitis. A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy. Arch Dermatol 1982;118:263-266.
252. Riedlinger WF, Hurley MY, Dehner LP, et al. Mucoepidermoid carcinoma of the skin: A distinct entity from adenosquamous carcinoma: A case study with a review of the literature. Am J Surg Pathol 2005; 29:131-135.
253. Bondeson L. Malignant dermal eccrine cylindroma. Acta Dermatol Venereol 1979;59:92-94.
254. Boulond A, Clerens A, Signard H. Cylindrome malin. Dermatologica 1979;158:203-207.
255. Urbanski SJ, From L, Abramowicz A. Metamorphosis of dermal cylindroma: Possible relation to malignant transformation. J Am Acad Dermatol 1985;12: 188-195.
256. Rockerbie N, Solomon AR, Woo TY, et al. Malignant dermal cylindroma in a patient with multiple dermal cylindromas, trichoepitheliomas, and bilateral dermal analogue tumors of the parotid gland. Am J Dermatopathol 1989;11:353-359.
257. Lyon JB, Rouillard LM. Malignant degeneration of turban tumor of the scalp. Trans St John’s Hosp Dermatol Soc 1961;46:74-77.
258. Grouls V, Iwaszkiewicz J, Berndt R. Malignant dermal cylindroma. Pathologe 1991;12:157-160.
259. Dabska M. Malignant transformation of eccrine spiradenoma. Pol Med J 1972;11:388-396.
260. Evans HL, Su WPD, Smith JL, et al. Carcinoma arising in eccrine spiradenoma. Cancer 1979;43: 1881-1884.
261. Cooper PH, Frierson Jr HF, Morrison AG. Malignant transformation of eccrine spiradenoma. Arch Dermatol 1985;121:1445-1448.
262. Wick MR, Kaye VN, Swanson PE, et al. Sweat gland carcinoma ex eccrine spiradenoma. Am J Dermatopathol 1987;9:90-98.
263. Argenyi AZ, Nguyen AV, Balogh K, et al. Malignant eccrine spiradenoma: A clinicopathologic study. Am J Dermatopathol 1990;12:335-343.
264. Varsa EW, Jordan SW. Fine needle aspiration cytology of malignant spiradenoma arising in congenital eccrine spiradenoma. Acta Cytol 1990;34:275-277.
265. Zamboni AC, Zamboni WA, Ross DS. Malignant eccrine spiradenoma of the hand. J Surg Oncol 1990;43:131-133.
266. Yaremchuk MJ, Elias LS, Graham RR, et al. Sweat gland carcinoma of the hand: Two cases of malignant eccrine spiradenoma. J Hand Surg 1984;9:910-914.
267. McKee PH, Fletcher CD, Rasbridge SA. The enigmatic eccrine epithelioma (eccrine syringomatous carcinoma). Am J Dermatopathol 1990;12:552-561.
268. Pizinger K, Michal M. Malignant cylindroma in Brooke-Spiegler syndrome. Dermatology 2000;201: 255-257.
269. Jamshidi M, Nowak MA, Chiu YT, et al. Giant malignant eccrine spiradenoma of the scalp. Dermatol Surg 1999;25:45-48.
270. Brownstein MH, Helwig EB. Metastatic tumors of the skin. Cancer 1972;29:1298-1307.
271. Brownstein MH, Helwig EB. Patterns of cutaneous metastasis. Arch Dermatol 1972;105:862-868.
272. Wick MR, Goellner JR, Wolfe JT, et al. Adnexal carcinomas of the skin: I. Eccrine carcinomas. Cancer 1985;56:1147-1162.
273. El-Domeiri AA, Brasfield RD, Huvos AG, et al. Sweat gland carcinoma: A clinicopathologic study of 83 patients. Ann Surg 1971;173:270-274.
274. Kay S, Hall WEB. Sweat gland carcinoma with proved metastases. Cancer 1954;7:373-376.
275. Okada N, Ota J, Sato K, et al. Metastasizing sweat gland carcinoma. Arch Dermatol 1984;120:768-769.
276. Miller WL. Sweat gland carcinoma: A clinicopathologic problem. Am J Clin Pathol 1967;47:767-780.
277. Swanson PE, Mazoujian G, Mills SE, et al. Immunoreactivity for estrogen receptor protein in sweat gland tumors. Am J Surg Pathol 1991;15:835-841.
278. Swanson PE, Wick MR. Immunohistochemistry of cutaneous tumors. In: Leong ASY (ed). Applied Immunohistochemistry for the Surgical Pathologist. Edward Arnold: London, 1993, pp 269-308.
279. Wong TY, Suster S, Nogita T, et al. Clear cell eccrine carcinomas of the skin: A clinicopathologic study of nine patients. Cancer 1994;73:1631-1643.
280. Suster S. Clear cell tumors of the skin. Semin Diagn Pathol 1996;13:40-59.
281. Headington JT, Niederhuber JE, Beals TF. Malignant clear cell acrospiroma. Cancer 1978;41:641-647.
282. Kersting DW. Clear cell hidradenoma and hidradenocarcinoma. Arch Dermatol 1963;87:323-333.
283. Keasbey LE, Hadley GG. Clear cell hidradenoma: Report of three cases with widespread metastases. Cancer 1954;7:934-952.
284. McKenzie DH. A clear-cell hidradenocarcinoma with metastases. Cancer 1957;10:1021-1023.
285. Chung CK, Hefferman AH. Clear cell hidradenoma with metastasis. Plast Reconstr Surg 1971;48: 177-179.
286. Czarnecki DB, Aarous I, Dowling JP. Malignant clear cell hidradenoma: A case report. Acata Dermatol Venereol 1982;62:173-176.
287. Hernandez-Perez E, Cestoni-Parducci R. Nodular hidradenoma and hidradenocarcinoma: A 10 year review. J Am Acad Dermatol 1985;12:15-20.
288. Kwon TJ, Ro JY, Mackay B. Clear-cell carcinoma: An ultrastructural study of 57 tumors from various sites. Ultrastruct Pathol 1996;20:519-527.
289. Tolia BM, Whitmore WF. Solitary metastasis from renal cell carcinoma. J Urol 1975;114:836-838.
290. Connor DH, Taylor HB, Helwig EB. Cutaneous metastases of renal cell carcinoma. Arch Pathol 1963;76:339-346.
291. Sharvill DE. Mixed salivary-type tumor of the skin with malignant recurrence. Br J Dermatol 1962;74: 103-104.
292. Rosborough D. Malignant mixed tumors of the skin. Br J Surg 1963;50:697-699.
293. Matz LR, McCully DJ, Stokes BAR. Metastasizing chondroid syringoma: A case report. Pathology 1961;1:77-81.
294. Hilton JMN, Blackwell JB. Metastasizing chondroid syringoma. J Pathol 1972;109:167-170.
295. Webb JN, Stott WG. Malignant chondroid syringoma of the thigh. J Pathol 1975;116:43-46.
296. Botha JBC, Kahn LB. Aggressive chondroid syringoma. Arch Dermatol 1978;114:954-955.
297. Ishimura E, Iwamoto H, Kobashi Y, et al. Malignant chondroid syringoma. Report of a case with widespread metastasis and review of pertinent literature. Cancer 1983;52:1966-1973.
298. Scott A, Metcalf S. Cutaneous malignant mixed tumor. Am J Dermatopathol 1988;10:335-342.
299. Shvili D, Rothem A. Fulminant metastasizing chondroid syringoma of the skin. Am J Dermatopathol 1986;8:321-325.
300. Harrist TJ, Aretz TH, Mihm Jr MC, et al. Cutaneous malignant mixed tumor. Arch Dermatol 1981;117: 719-724.
301. Pinto de Moraes H, Herrera GA, Mendonca AM, et al. Metastatic malignant mixed tumor of the skin: Ultrastructural and immunohistochemical characterization, histogenetic considerations, and comparison with benign mixed tumors of skin and salivary glands. Appl Pathol 1986;4:199-208.
302. Redono C, Rocamora A, Villoria F, et al. Malignant mixed tumor of the skin: Malignant chondroid syringoma. Cancer 1982;49:1690-1696.
303. De Francesco V, Frattasio A, Pillon B, et al. Carcinosarcoma arising in a patient with multiple cylindromas. Am J Dermatopathol 2005;27:21-26.
304. Wick MR, Swanson PE. ‘Carcinosarcomas’— current perspectives and a historical review of nosological concepts. Semin Diagn Pathol 1993;10: 118-127.
305. Wick MR, Coffin CM. Sweat glands and pilar carcinomas. In: Wick MR (ed). Pathology of Unusual Malignant Cutaneous Tumors. Marcel-Dekker: New York, 1985, pp 1-76.
306. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972;105:107-110.
307. Busam DJ, Gellis S, Shimamura A, et al. Small cell sweat gland carcinoma in childhood. Am J Surg Pathol 1998;22:215-220.
308. Crowson AN, Magro CM, Mihm Jr MC. The Melanocytic Proliferations: A Comprehensive Textbook of Pigmented Lesions. John Wiley and Sons: New York, 2001.
309. Jones RE, Ackerman AB. Extramammary Paget’s disease: A critical reappraisal. Am J Dermatopathol 1979;1:101-132.
310. Kuan SF, Montag AG, Hart J, et al. Differential expression of mucin genes in mammary and extramammary Paget’s disease. Am J Surg Pathol 2001;25: 1469-1477.
311. Jones RE. Mammary Paget’s disease without underlying carcinoma. Am J Dermatopathol 1985;7: 361-365.
312. Mori O, Hachisuka H, Nakano S, et al. A case of mammary Paget’s disease without an underlying carcinoma: Microscopic analysis of the DNA content in Paget cells. J Dermatol 1994;21:160-165.
313. Willman JH, Golitz LE, Fitzpatrick JE. Vulvar clear cells of Toker. Precursors of extramammary Paget’s disease. Am J Dermatopathol 2005;27:185-188.
314. Honda Y, Egawa K. Extramammary Paget’s disease not only mimicking but also accompanying condyloma accuminatum. Dermatology 2005;210:315-318.
315. Lee SC, Roth LM, Ehrlich C, et al. Extramammary Paget’s disease of the vulva: A clinicopathologic study of 13 cases. Cancer 1977;39:2540-2549.
316. Boehm F, Morris JML. Paget’s disease and apocrine gland carcinoma of the vulva. Obster Gynecol 1971;38:185-192.
317. Hart WR, Millman JB. Progression of intraepithelial Paget’s disease of the vulva to invasive carcinoma. Cancer 1977;40:2333-2337.
318. Mitsudo S, Nakanishi I, Koss LG. Paget’s disease of the penis and adjacent skin: Its association with fatal sweat gland carcinoma. Arch Pathol Lab Med 1981;105:518-520.
319. Knauer Jr WJ, Whorton CM. Extramammary Paget’s disease originating in Mill’s glands of the eyelid. Trans Am Acad Ophthalmol Otolaryngol 1963;67: 829-833.
320. Nadji M, Morales AR, Girtanner RE, et al. Paget’s disease of the skin: A unifying concept of histogenesis. Cancer 1982;50:2203-2206.
321. Rayne SC, Santa Cruz DJ. Anaplastic Paget’s disease. Am J Surg Pathol 1992;16:1085-1091.
322. Mazoujian G, Pinkus GS, Haagensen DE. Extramammary Paget’s disease: Evidence for an apocrine origin. Am J Surg Pathol 1984;8:43-50.
323. Satoh F, Umemura S, Osamura RY. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue. Breast Cancer 2000;7:49-55.
324. Kariniemi AL, Ramaekers F, Lehto VP, et al. Paget cells express cytokeratins typical of glandular epithelia. Br J Dermatol 1985;112:179-183.
325. Hitchcock A, Topham S, Bell J, et al. Routine diagnosis of mammary Paget’s disease. Am J Surg Pathol 1992;16:58-61.
326. Helm KF, Goellner JR, Peters MS. Immunohistochemical stains in extramammary Paget’s disease. Am J Dermatopathol 1992;14:402-407.
327. Liegl B, Horn LC, Moinfar F. Androgen receptors are frequently expressed in mammary and extramammary Paget’s disease. Mod Pathol 2005; May 13 (Epub ahead of print).
328. Reich O, Liegl B, Tamussino K, et al. P185HER2 overexpression and HER2 oncogene amplification in recurrent vulvar Paget’s disease. Mod Pathol 2005;18:354-357.
329. Brummer O, Stegner HE, Bohmer G, et al. HER-2/neu expression in Paget’s disease of the vulva and female breast. Gynecol Oncol 2004;95:336-340.
330. Takeshita K, Kzumoi S, Ebuchi M, et al. A case of rectal carcinoma concomitant with pagetoid lesion in the perianal region. Gastroenterol Jpn 1978;13: 85-95.
331. McKee PH, Hertogs KT. Endocervical adenocarcinoma and vulvar Paget’s disease: A significant association. Br J Dermatol 1980;103:443-448.
332. Degefu S, O’Quinn AG, Dhurandhar HN. Paget’s disease of the vulva and urogenital malignancies. Gynecol Oncol 1986;25:347-354.
333. Ojeda VJ, Heenen PJ, Watson SH. Paget’s disease of the groin associated with adenocarcinoma of the urinary bladder. J Cutan Pathol 1987;14:227-231.
334. Fujimoto A, Takata M, Hatta N, et al. Expression of structurally unaltered androgen receptor in extramammary Paget’s disease. Lab Invest 2000;80:1465-1471.
335. Diaz-de-Leon E, Carcangiu ML, Prieto VG, et al. Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor. Am J Clin Pathol 2000;113:572-575.
336. Soini Y. Claudins 2, 3, 4 and 5 in Paget’s disease and breast carcinoma. Hum Pathol 2004;35:1531-1536.
337. Bogner PN, Su LD, Fullen DR. Cluster designation 5 staining of normal and non-lymphoid neoplastic skin. J Cutan Pathol 2005;32:50-54.